Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Dec;14(12):1463-1491.
doi: 10.1016/j.jsxm.2017.05.018.

Female Sexual Dysfunction-Medical and Psychological Treatments, Committee 14

Sheryl A Kingsberg  1 , Stanley Althof  2 , James A Simon  3 , Andrea Bradford  4 , Johannes Bitzer  5 , Joana Carvalho  6 , Kathryn E Flynn  7 , Rossella E Nappi  8 , Jennifer B Reese  9 , Roya L Rezaee  1 , Leslie Schover  10 , Jan L Shifrin  11
Affiliations
Review

Female Sexual Dysfunction-Medical and Psychological Treatments, Committee 14

Sheryl A Kingsberg et al. J Sex Med. 2017 Dec.

Erratum in

  • Erratum.
    [No authors listed] [No authors listed] J Sex Med. 2018 Feb;15(2):270. doi: 10.1016/j.jsxm.2017.12.002. J Sex Med. 2018. PMID: 29425667 No abstract available.

Abstract

Introduction: Since the millennium we have witnessed significant strides in the science and treatment of female sexual dysfunction (FSD). This forward progress has included (i) the development of new theoretical models to describe healthy and dysfunctional sexual responses in women; (ii) alternative classification strategies of female sexual disorders; (iii) major advances in brain, hormonal, psychological, and interpersonal research focusing on etiologic factors and treatment approaches; (iv) strong and effective public advocacy for FSD; and (v) greater educational awareness of the impact of FSD on the woman and her partner.

Aims: To review the literature and describe the best practices for assessing and treating women with hypoactive sexual desire disorder, female sexual arousal disorder, and female orgasmic disorders.

Methods: The committee undertook a comprehensive review of the literature and discussion among themselves to determine the best assessment and treatment methods.

Results: Using a biopsychosocial lens, the committee presents recommendations (with levels of evidence) for assessment and treatment of hypoactive sexual desire disorder, female sexual arousal disorder, and female orgasmic disorders.

Conclusion: The numerous significant strides in FSD that have occurred since the previous International Consultation of Sexual Medicine publications are reviewed in this article. Although evidence supports an integrated biopsychosocial approach to assessment and treatment of these disorders, the biological and psychological factors are artificially separated for review purposes. We recognize that best outcomes are achieved when all relevant factors are identified and addressed by the clinician and patient working together in concert (the sum is greater than the whole of its parts). Kingsberg SA, Althof S, Simon JA, et al. Female Sexual Dysfunction-Medical and Psychological Treatments, Committee 14. J Sex Med 2017;14:1463-1491.

Keywords: Female Orgasmic Dysfunction; Female Sexual Arousal Disorder; Female Sexual Dysfunction; Hypoactive Sexual Desire Disorder; Persistent Genital Arousal Disorder.

PubMed Disclaimer